SIRT1 and exocrine pancreatic carcinoma: To further confirm the in vitro interaction between SIRT1 and the CRL4B complex, we performed co-IP assays in four pancreatic carcinoma cell lines, and the results demonstrated that SIRT1 co-immunoprecipitated with the CRL4B complex, rather than CRL4A complex (Fig. 2C).